4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001636178-26-000005
CFO AND TREASURER sold 10,000 shares at an average $593.17 ($5,931,683)
- CFO AND TREASURER acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
EDGEMOND JAMES · CFO AND TREASURER
Table I: Non-derivative
23 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-30 | Exercise or conversion : show line 1 in the form 10b5-1 | +10,000 | $135.42 | $1,354,200 | 28,876 | D |
| 2026-03-30 | Sale : show line 2 in the form 10b5-1 | −40 | $581.73 | $23,269 | 28,836 | D |
| 2026-03-30 | Sale : show line 3 in the form 10b5-1 | −120 | $583.52 | $70,023 | 28,716 | D |
| 2026-03-30 | Sale : show line 4 in the form 10b5-1 | −120 | $585.17 | $70,221 | 28,596 | D |
| 2026-03-30 | Sale : show line 5 in the form 10b5-1 | −437 | $586.27 | $256,202 | 28,159 | D |
| 2026-03-30 | Sale : show line 6 in the form 10b5-1 | −860 | $587.35 | $505,125 | 27,299 | D |
| 2026-03-30 | Sale : show line 7 in the form 10b5-1 | −1,487 | $588.42 | $874,974 | 25,812 | D |
| 2026-03-30 | Sale : show line 8 in the form 10b5-1 | −1,196 | $589.23 | $704,724 | 24,616 | D |
| Open-market sales · 10,000 sh · avg $593.17 · $5,931,683 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-03-30 | Exercise or conversion : show line 24 in the form 10b5-1 Stock Option | −10,000 | 132,500 | D |
Loading xslF345X06/primarydocument.xml…